ADHERENCE TO COPD TREATMENT: IS IT REALLY OF CRUCIAL IMPORTANCE?
Journal Title: Астма и Аллергия - Year 2019, Vol 1, Issue 3
Abstract
Poor adherence is a major challenge on the way to treatment optimization of the treatment of in patients with chronic obstructive pulmonary disease (COPD). The 40–60 % of the patients with COPD have adherent level of adherence 80 % or more of prescribed doses. The main reasons of low adherence are absence lack of skills to use inhaler correctly, old age, cognitive and depressive disorders, poor explanation of the target and regimen of the treatment regimen and its goals to patient, insufficient trust to in doctor and his/her recommendations. The keys measures to improve adherence to treatment are associated with establishment of the high-level doctor-patient cooperation between the patient and doctor, explanation to the patient target of goals and treatment regimen of the treatment and repeated trainings to use in correct inhaler use correctly. Our results states that adherence to treatment could be improved from 43.7 to 83.5 % within 2 months.
Authors and Affiliations
Y. M. Mostovoy, A. A. Sidorov, N. S. Slepchenko
Keywords
Related Articles
- EP ID EP656880
- DOI 10.31655/2307-3373-2019-3-56-60
- Views 126
- Downloads 0
Influence of recovery treatment based on the haloaerosoltherapy upon non-specific defense of children with recurrent respiratory diseases
Abstract Objective was to study the influence of different treatment complexes based on haloaerosoltherapy with increased concentration of rock-salt aerosol upon non-specific defense at children with recurrent respirator...
POSSIBILITIES OF COMPUTED TOMOGRAPHY IN EXAMINATION OF PATIENTS WITH BRONCHIAL ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND IN THE STUDY OF BONE MINERAL DENSITY
he article presents information about the possibilities of computed tomography (CT) in the examination of patients with bronchial asthma (BA), chronic obstructive pulmonary disease (COPD) and in the study...
FEATURES OF BRONCHIAL ASTHMA WITH NEUTROPHILIC INFLAMMATION
Bronchial asthma (BA) is a heterogeneous chronic inflammatory respiratory disease. Usually it is possible to achieve and maintain disease control in most patients. But there remains a part of...
NEBULIZED THERAPY: PRACTICAL ASPECTS
Recently, nebulized therapy has become increasingly popular in practical medicine due to the effectiveness, accessibility and appearance of a wide range of nebulized dosage forms. Today the basis of nebulized therapy is...
EVALUATION OF THE EFFICACY AND SAFETY OF COMBINED USE OF FORMOTEROL AND FLUTICASONE PROPIONATE IN THE TREATMENT OF PATIENTS WITH BRON-CHIAL ASTHMA AND COMORBID CORONARY HEART DISEASE
TAim: to evaluate the clinical efficacy and safety of the use of formoterol (Zafiron medicine, «Adamed Pharma S.A» pharmaceutical company) and fluticasone propionate (Flutixon medicine, «Adamed Pharma S.A» ph...